An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in HIV-1 Infected Patients

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Biocad

ClinicalTrials.gov Identifier:

NCT02103439

First received: April 1, 2014

Last updated: NA

Last verified: April 2014

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2015
Estimated Primary Completion Date:	August 2014 (Final data collection date for primary outcome measure)